![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Is Selenium Deficiency the Cause of Uraemic Cardiomyopathy?
We studied the relationship between serum selenium (Se) and left ventricular performance in 33 patients on maintenance haemodialysis. Low serum Se was frequent. However, there were no significant differences i...
-
Article
Ophthalmological screening for von Hippel-Lindau disease
Forty seven individuals (from 16 kindreds) without prior evidence of retinal hae-mangiomas underwent full ophthalmological assessment as part of a comprehensive screening programme for Von Hippel-Lindau diseas...
-
Article
Physical map** of chromosome 3p25-p26 by flourescence in situ hybridisation (FISH)
As part of our effort to isolate and characterise the von Hippel-Lindau (VHL) disease gene, we constructed a physical map of chromosome 3p25-26 by fluorescence in situ hybridisation (FISH) studies on a panel o...
-
Chapter
Molecular Genetics of Wilms’ Tumour and Renal Cell Carcinoma
It is now generally accepted that cancer is caused by an accumulation of genetic mutations. However, only a small proportion of cancer-associated gene mutations are inherited (i.e. are germline mutations); the...
-
Article
Irish college of ophthalmologists
-
Article
Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene
Experimental conditions for detection of germline deletions of the von Hippel-Lindau (VHL) gene by means of long polymerase chain reaction have been established. Primers were designed to analyse the VHL gene i...
-
Article
Analysis of the TSC1and TSC2genes in sporadic renal cell carcinomas
The genetic events involved in the aetiology of non-clear-cell renal cell carcinoma (RCC) and a proportion of clear cell RCC remain to be defined. Germline mutations of the TSC1and TSC2genes cause tuberous sclero...
-
Article
Open AccessSLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
The 3p21.3 RASSF1A tumour suppressor gene (TSG) provides a paradigm for TSGs inactivated by promoter methylation rather than somatic mutations. Recently, we identified frequent promoter methylation without somati...
-
Article
Open AccessInvestigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma
Germline mutations in the succinate dehydrogenase (SDH) (mitochondrial respiratory chain complex II) subunit B gene, SDHB, cause susceptibility to head and neck paraganglioma and phaeochromocytoma. Previously, we...
-
Article
Open AccessEpigenetic inactivation of SLIT3 and SLIT1 genes in human cancers
In Drosophila, the Slit gene product, a secreted glycoprotein, acts as a midline repellent to guide axonal development during embryogenesis. Three human Slit gene orthologues have been characterised and recent...
-
Article
Open AccessEpigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour
Epigenetic alterations in the 11p15.5 imprinted gene cluster are frequent in human cancers and are associated with disordered imprinting of insulin-like growth factor (IGF)2 and H19. Recently, an imprinted gene c...
-
Article
Identification of novel VHL targets that are associated with the development of renal cell carcinoma
von Hippel–Lindau (VHL) disease is a dominantly inherited family cancer syndrome characterized by the development of retinal and central nervous system haemangioblastomas, renal cell carcinoma (RCC) and phaeoc...
-
Article
Open AccessFunctional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma
Promoter region hypermethylation and transcriptional silencing is a frequent cause of tumour suppressor gene (TSG) inactivation in many human cancers. Previously, to identify candidate epigenetically inactivat...
-
Article
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer
RASSF2 is a recently identified member of a class of novel tumour suppressor genes, all containing a ras-association domain. RASSF2 resides at 20p13, a region frequently lost in human cancers. In this report w...
-
Article
SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis
Mutations in SDHB are one of the causes of hereditary paraganglioma syndrome. Germline mutations in SDHB predispose to the development of head and neck paragangliomas and phaeochromocytomas. Renal tumours are ...
-
Article
Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma
Promoter region hyermethylation and transcriptional silencing is a frequent cause of tumour suppressor gene (TSG) inactivation in many types of human cancers. Functional epigenetic studies, in which gene expre...
-
Article
The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways
The Ras-assocation domain family (RASSF) of tumor suppressor proteins until recently contained six proteins named RASSF1–6. Recently, four novel family members, RASSF7–10, have been identified by homology searche...
-
Article
Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis
We have recently described the N-terminal RAS association domain family of genes, RASSF7–10. Previously, we cloned the N-terminal RASSF10 gene and demonstrated frequent methylation of the associated 5′-CpG island...
-
Article
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
The detection of promoter region hypermethylation and transcriptional silencing has facilitated the identification of candidate renal cell carcinoma (RCC) tumour suppressor genes (TSGs). We have used a genome-...
-
Article
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
The risks of cancers other than breast and ovarian amongst BRCA1 and BRCA2 mutation carriers are based on relatively few family based studies with the risk of specific cancers tested in population based samples o...